Sugi Predict

Sugi Predict / Compounds / SCHEMBL503667

SCHEMBL503667

SCHEMBL503667

O=C(O)Cc1cc(F)ccc1F

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TSHR P16473 1/20 0.53
▸ AGBL2 Q5U5Z8 1/20 0.48
▸ CXCL8 P10145 2/20 0.47
▸ CES2 O00748 2/20 0.47
▸ CES1 P23141 2/20 0.47
▸ MAPK8 P45983 1/20 0.47
▸ RIPK1 Q13546 1/20 0.45
▸ SIGMAR1 Q99720 1/20 0.45
▸ AKR1C3 P42330 1/20 0.44
▸ AKR1C2 P52895 1/20 0.44
▸ AKR1B1 P15121 2/20 0.43
▸ AKR1A1 P14550 1/20 0.43
▸ PSEN1 P49768 1/20 0.42
▸ PSEN2 P49810 1/20 0.42
▸ APH1B Q8WW43 1/20 0.42
▸ NCSTN Q92542 1/20 0.42
▸ APH1A Q96BI3 1/20 0.42
▸ PSENEN Q9NZ42 1/20 0.42
▸ CA3 P07451 1/20 0.41
▸ CA6 P23280 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29471363 1.00 TSHR (0.53) TSHRAGBL2CXCL8CES2CES1
SCHEMBL6858298 0.85 CES2 (0.48) TSHRCES2CES1MAPK8RIPK1
SCHEMBL19987891 0.85 MMP1 (0.50) TSHRCXCL8MMP1MMP2MMP9
SCHEMBL503325 0.83 TSHR (0.53) TSHRAGBL2CXCL8CES2CES1
SCHEMBL29459931 0.83 TSHR (0.53) TSHRAGBL2CXCL8CES2CES1
SCHEMBL28061383 0.83 CES2 (0.47) TSHRCES2CES1MAPK8RIPK1
SCHEMBL1115079 0.82 MAPK8 (0.52) CES2CES1MAPK8RIPK1SIGMAR1
SCHEMBL892996 0.82 MAPK8 (0.46) TSHRCES2CES1MAPK8RIPK1
SCHEMBL868684 0.82 KEAP1 (0.51) CXCL8AKR1C3AKR1C2AKR1B1
SCHEMBL3907433 0.82 EGFR (0.49) TSHRAKR1B1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 371 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4661890-A1 PTP1B/TC-PTP DUAL INHIBITORS AND PROTEIN DEGRADERS Purdue Research Foundation (US) 2025-12-17 — — EP claimed
WO-2024167565-A1 PTP1B/TC-PTP DUAL INHIBITORS AND PROTEIN DEGRADERS PURDUE RESEARCH FOUNDATION (US) 2024-08-15 — — WO claimed
US-10072043-B2 Inhibitors of protein tyrosine phosphatases INDIANA UNIVERSITY RESEARCH AND TECHNOLOGY CORPORATION (US) 2018-09-11 — — US claimed
CN-106631727-A Method for preparing 2,5-difluorobenzaldehyde through continuous oxidation of 2,5-difluorotoluene 常州大学 2017-05-10 — — CN claimed
US-20160176922-A1 INHIBITORS OF PROTEIN TYROSINE PHOSPHATASES Indiana University Research and Technology Corpora tion (US) 2016-06-23 — — US claimed
US-9217012-B2 Inhibitors of protein tyrosine phosphatases INDIANA UNIVERSITY RESEARCH AND TECHNOLOGY CORPORATION (US) 2015-12-22 — — US claimed
US-20120088720-A1 INHIBITORS OF PROTEIN TYROSINE PHOSPHATASES INDIANA UNIVERSITY RESEARCH & TECHNOLOGY CORPORATI (US) 2012-04-12 — — US claimed
WO-2010118241-A2 INHIBITORS OF PROTEIN TYROSINE PHOSPHATASES INDIANA UNIVERSITY RESEARCH & TECHNOLOGY CORPORATION (US) 2010-10-14 — — WO claimed
US-7732625-B2 Colorant compounds XEROX CORPORATION (US) 2010-06-08 — — US claimed
US-7311767-B2 Forming a salt of a liquid phase change ink carrier of stearyl stearamide, an amine substituted Xanthene, acridine, anthracene or thioxanthene chromogen, and a metal salt capable of forming a compound with two chromogens XEROX CORPORATION (US) 2007-12-25 — — US claimed
US-20060021546-A1 Processes for preparing phase change inks XEROX CORPORATION 2006-02-02 — — US claimed
US-20060020141-A1 Metallized dye XEROX CORPORATION 2006-01-26 — — US claimed
US-20060016369-A1 PHASE CHANGE INKS XEROX CORPORATION 2006-01-26 — — US claimed
US-6946025-B2 Process for preparing tetra-amide compounds XEROX CORPORATION (US) 2005-09-20 — — US claimed
CN-1651392-A 2-and 2, 5-substituted phenyl keto-enols BAYER AG (DE) 2005-08-10 — — CN claimed
US-20050090690-A1 Process for preparing tetra-amide compounds XEROX CORPORATION 2005-04-28 — — US claimed
US-20020010204-A1 2- and 2,5-substituted phenylketoenols LIEB FOLKER (DE) 2002-01-24 — — US claimed
CN-1232450-A 2-and 2, 5-substituted phenyl keto-enols BAYER AG (DE) 1999-10-20 — — CN claimed
EP-0915846-A2 2- AND 2,5-SUBSTITUTED PHENYLKETOENOLS BAYER AG (DE) 1999-05-19 — — EP claimed
WO-1998005638-A2 2- AND 2,5-SUBSTITUTED PHENYLKETOENOLS BAYER AKTIENGESELLSCHAFT (DE) 1998-02-12 — — WO claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10072043-B2 Inhibitors of protein tyrosine phosphatases PTPRCAP, PTPRF, PTPRS TSHR 1605/4885AGBL2 127/4885CXCL8 4803/4885
US-20160176922-A1 INHIBITORS OF PROTEIN TYROSINE PHOSPHATASES PTPRCAP, PTPRF, PTPRS TSHR 1605/4885AGBL2 127/4885CXCL8 4803/4885
US-20060020141-A1 Metallized dye CDYL, CDY1; CDY1B, CDYL2 TSHR 2894/4885AGBL2 1525/4885CXCL8 2552/4885
US-20050090690-A1 Process for preparing tetra-amide compounds TAF9, TAF5, TAF1 TSHR 4082/4885AGBL2 3732/4885CXCL8 1088/4885
US-20020010204-A1 2- and 2,5-substituted phenylketoenols CYP1B1, CYP4X1, CYP1A1 TSHR 3286/4885AGBL2 2260/4885CXCL8 4355/4885
US-20120088720-A1 INHIBITORS OF PROTEIN TYROSINE PHOSPHATASES PTPRCAP, PTPRF, PTPRS TSHR 1605/4885AGBL2 127/4885CXCL8 4803/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.